Business Context and Reporting Period
Company: OneMedNet Corporation (ONMD)
Filing Type: Form 8-K (Current Report)
Date of Report: November 4, 2024
Reporting Period: This filing addresses the fiscal years ended December 31, 2023, and December 31, 2022, specifically regarding the reliability of previously issued financial statements.
Key Financial Metrics
This filing is a notification of non-reliance on prior financial statements and does not contain specific revenue, profit, cash flow, margin, debt, or liquidity figures. The filing states that errors were identified in the accounting for convertible notes, warrants, stock-based compensation expense, and the de-SPAC transaction (including associated liabilities and recapitalization). Specific adjusted values are not provided in this text; investors must refer to the Form 10-K/A filed on November 5, 2024, for restated numbers.
Material Changes Versus Prior Period
- Non-Reliance Determination: The Audit Committee resolved that the Annual Report on Form 10-K for the year ended December 31, 2023 (originally filed April 9, 2024), should no longer be relied upon due to errors.
- Restatement Action: The Company filed an amended Annual Report (Form 10-K/A) on November 5, 2024, to restate the financial statements for the years ended December 31, 2023, and 2022.
- Auditor Change: The Company dismissed its former auditor, BF Borgers CPA PC, on May 6, 2024, following an SEC settlement regarding audit failures. WithumSmith+Brown, PC was retained on June 3, 2024, to perform reaudits.
Guidance, Outlook, and Risks
Management Commentary: The reaudits conducted by the new auditor revealed that sufficient audit procedures were not performed by the former auditor. Management applied new accounting procedures to historical data, identifying errors in specific complex financial instruments and transaction accounting.
Risks and Contingencies:
- Audit Integrity Risk: The filing highlights a significant breakdown in the prior audit process, leading to a permanent ban of the former auditor from practicing before the SEC.
- Accounting Errors: Errors were found in the treatment of convertible notes, warrants, stock-based compensation, and de-SPAC transaction liabilities.
Unusual Items: The dismissal of the auditor due to an SEC enforcement action and the subsequent requirement to restate two years of financials constitute unusual and material corporate governance events.
Investor Verification Checklist
- Review the Form 10-K/A filed on November 5, 2024, to obtain the specific restated financial figures for 2022 and 2023.
- Verify the magnitude of adjustments made to convertible notes, warrants, and stock-based compensation.
- Confirm the status of the de-SPAC transaction liabilities and recapitalization accounting in the amended report.
- Assess the impact of the auditor change on future financial reporting reliability and internal controls.